Home » Newsletters » BioWorld Science

BioWorld Science

July 1, 2010

View Archived Issues

PET/CT tracer anti-3-[18F]-FACBC effectively detects recurrent prostate cancer

Integrin alpha-V/beta-6 shows potential as biomarker for pancreatic cancer

Dexrazoxane is cardioprotective in rat model of myocardial infarction

Solvay discloses new potassium channel blockers

GlaxoSmithKline presents new AMPA receptor agonists

Centocor Ortho Biotech and Medivir claim new NS5B polymerase inhibitors

TopoTarget presents novel Nampt inhibitors

Novel P2X3 and P2X2/3 receptor antagonists claimed by Roche

TAK-701 shows promise in nonhematologic tumors

TXA-127 obtains FDA orphan drug status to enhance stem cell engraftment

Futura Medical and GSK join to develop TPR-100 for topical pain relief

Acotiamide meets primary endpoints in phase III trial in functional dyspepsia

FDA grants orphan drug status to Octreolin for oral treatment of acromegaly

AMAG and Takeda begin global registrational program of ferumoxytol

TZP-102 improves diabetic gastroparesis-related symptoms in phase II trial

Posaconazole for Chagas' disease enters phase II trial in South America

Vitae receives milestone payment as 11-beta-HSD1 inhibitor advances to phase I

EMA issues encouraging scientific advice on phase III perifosine trial in colorectal cancer

Tolerx begins confirmatory phase III trial of otelixizumab in type 1 diabetes

Pluristem to design phase IIb trials of PLX-PAD in CLI and claudication

Cubist meets objectives in phase II CXA-101 urinary tract infection study

Alnylam obtains approval to initiate phase I ALN-TTR01 study in amyloidosis

Alimera submits Iluvien NDA to FDA for diabetic macular edema

Immunovaccine and Oncothyreon to jointly develop cancer vaccine

Single-molecule digital ELISA shows potential in diagnosing prostate cancer

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...